1.
ICH Guidelines, K U, l H. DEVELOPMENT AND VALIDATION OF OSIMERTINIB IN TABLET DOSAGE FORM BY RP-HPLC. IJPAR [Internet]. 2025 Oct. 29 [cited 2026 Apr. 17];14(4):1186-99. Available from: https://ijpar.com/index.php/ijpar/article/view/1023